flu news from FierceBiotech
NewsEmergent adds new space for biotech start-ups
Emergent Technologies Inc has doubled its office space, taking new digs in Austin that includes new laboratory space for the biotech companies that it helps foster. ETI specializes in creating new Read more...
ALSO NOTED: GSK releases new Cervarix data; FDA mulls DTC ads; and much more...
> GlaxoSmithKline has released new Cervarix data that demonstrates the vaccine's ability to generate a high and sustained level of antibodies to neutralize the two most prevalent strains of Read more...
Intercell snaps up Iomai in $189M deal
The little Maryland-based vaccine developer Iomai, which has posted some impressive data on a new therapy for Read more...
Acambis lands $425M smallpox vaccine contract
The U.K.'s Acambis has won a $425 million contract to supply the CDC with its smallpox vaccine for 10 years. Acambis will establish a U.S.-based manufacturing capability for ACAM2000 and deliver a Read more...
Feds ok Iomai Phase II adjuvant patch study
Health and Human Services is giving Iomai the green light to do a mid-stage dose ranging study of its adjuvant patch for bird flu vaccine. HHS provided a $128 million contract backing Iomai's effort Read more...
Peregrine reports positive cancer data
Peregrine Pharmaceuticals is posting positive data from two ongoing, mid-stage trials of its cancer therapy Cotara. The trial data assessed Cotara's safety and efficacy in treating patients with Read more...
Breakthrough reported in flu vaccine research
A Japanese chemical company saw its stock shoot up 20 percent this morning, the maximum allowed on the Japanese market, after researchers for NOF and Japan's National Institute of Infectious Diseases Read more...
Novartis established nonprofit vaccine institute
Novartis has established the Novartis Vaccines Institute for Global Health, a nonprofit venture that will take aim at diseases in the developing world. The NVGH, which will be separate from Novartis' Read more...
SPOTLIGHT: Research links efficacy to thoughts
A patient's thoughts and feelings can play a big role in determining just how effective their annual flu shot can be, says a new study from the University of Wisconsin. In the study, researchers Read more...
SPOTLIGHT: Gates backs new vaccine technology
PATH is using a $39 million grant from the Gates Foundation to help developing countries identify ways to manufacture and stockpile vaccines that could be used to defend their populations against an Read more...
| Press ReleasesPRESS RELEASE: GlaxoSmithKline increases US seasonal flu vaccine shipments GlaxoSmithKline increases US seasonal flu vaccine shipments Company is shipping FLUARIX® and FLULAVAL™ to U.S. customers for 2007-2008 season PHILADELPHIA, PA, September 13, 2007 — Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends